Synthetic biology, engineering biology, market expectation

Area of Science:

• Biological Engineering
• Biotechnology
• Systems Biology

Background:

• The terms 'engineering biology' and 'synthetic biology' are increasingly used by organizations aiming to leverage biological systems.
• A need exists to clarify the distinctions and overlaps between these two related fields.

Purpose of the Study:

• To differentiate 'engineering biology' from 'synthetic biology' based on their current applications and descriptions.
• To acknowledge the significant overlaps and complementarity between the two terms.

Main Methods:

• Observational analysis of how 'engineering biology' and 'synthetic biology' are described in practice.
• Comparative assessment of the application of both terms in commercial and research contexts.

Main Results:

• 'Synthetic biology' is associated with the foundational goal of making biology engineerable, driving long-term research.
• 'Engineering biology' signifies the application of the synthetic biology platform and related technologies to address market needs.
• The adoption of 'engineering biology' reflects the maturation of synthetic biology into a technological platform for products and services.

Conclusions:

• While distinct, 'engineering biology' and 'synthetic biology' are complementary, with the former representing a more applied, market-oriented utilization of the latter's foundational principles.
• Understanding these differences is crucial for organizations navigating the evolving landscape of biological innovation.